Omnicell (OMCL) Cash & Current Investments (2010 - 2026)
Omnicell's (OMCL) quarterly Cash & Current Investments came in at $292.2 million in Q2 2026, down 26.77% year-over-year from $399.0 million in Q2 2025, and up 22.15% quarter-over-quarter from $239.2 million in Q1 2026.
Analysis
Omnicell (OMCL) Cash & Current Investments (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Cash & Current Investments for 17 consecutive years, with $292.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments fell 26.77% year-over-year to $292.2 million in Q2 2026; TTM through Jun 2026 was $292.2 million, a 26.77% decrease from a year earlier, with the FY2025 full-year figure at $196.5 million, down 46.77% from the prior year.
- Cash & Current Investments was $292.2 million for Q2 2026 at Omnicell, up from $239.2 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $570.6 million in Q3 2024 and troughed at $180.1 million in Q3 2025.
- A 5-year average of $373.1 million and a median of $379.5 million in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments soared 55.54% in 2023 and slumped 68.44% in 2025, its largest moves.
- Over 5 years, Cash & Current Investments stood at $374.8 million in 2022, then increased by 24.87% to $468.0 million in 2023, then dropped by 21.11% to $369.2 million in 2024, then plunged by 46.77% to $196.5 million in 2025, then surged by 48.69% to $292.2 million in 2026.
- The last three Cash & Current Investments figures came in at $292.2 million (Q2 2026), $239.2 million (Q1 2026), and $196.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 1.47 Bn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 292.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 292.20 Mn |
| Mar 31, 2026 | 239.22 Mn |
| Dec 31, 2025 | 196.52 Mn |
| Sep 30, 2025 | 180.10 Mn |
| Jun 30, 2025 | 399.00 Mn |
| Mar 31, 2025 | 386.83 Mn |
| Dec 31, 2024 | 369.20 Mn |
| Sep 30, 2024 | 570.63 Mn |
| Jun 30, 2024 | 556.78 Mn |
| Mar 31, 2024 | 512.36 Mn |
| Dec 31, 2023 | 467.97 Mn |
| Sep 30, 2023 | 446.84 Mn |
| Jun 30, 2023 | 445.58 Mn |
| Mar 31, 2023 | 384.21 Mn |
| Dec 31, 2022 | 374.77 Mn |
| Sep 30, 2022 | 312.80 Mn |
| Jun 30, 2022 | 286.47 Mn |
| Mar 31, 2022 | 295.16 Mn |
| Dec 31, 2021 | 378.11 Mn |
| Sep 30, 2021 | 511.27 Mn |